H.R. 3327 · 116th Congress

Drug Price Transparency for Medicare Patients Act of 2019

Stage
In committee
Sponsor
Francis Rooney
Introduced
2019-06-18
Latest action
2019-06-19 · Referred to the Subcommittee on Health.

Action history

  1. 2019-06-19Referred to the Subcommittee on Health.
  2. 2019-06-18Introduced in House
  3. 2019-06-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2019-06-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.